This Article Full Text Full Text (PDF) All Versions of this Article: 90/1/328    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hooft, L. Articles by Molthoff, C. F. M. Search for Related Content PubMed PubMed Citation Articles by Hooft, L. Articles by Molthoff, C. F. M. Related Collections Thyroid Endocrine Oncology

[¹⁸F]Fluorodeoxyglucose Uptake in Recurrent Thyroid Cancer Is Related to Hexokinase I Expression in the Primary Tumor

Departments of Nuclear Medicine and PET Research (L.H., A.A.M.v.d.V., O.S.H., G.J.J.T., C.F.M.M.), Clinical Epidemiology and Biostatistics (L.H., O.S.H., J.B.), and Pathology (P.J.v.D.), Vrije Universiteit Medical Center, Amsterdam, The Netherlands

Address all correspondence and requests for reprints to: Dr. C. F. M. Molthoff, Department of Nuclear Medicine and PET Research, Room 5A86, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: cfm.molthoff{at}vumc.nl.

Patients suspected of recurrent differentiated thyroid cancer (DTC) may require "blind" ¹³¹I therapy, with the disadvantage of unpredictable efficacy and toxicity. Alternatively, positron emission tomography (PET) with [¹⁸F]fluorodeoxyglucose (¹⁸FDG) can document the recurrence, thereby rationalizing therapeutic options. This study compared ¹⁸FDG uptake in vivo with biomarkers expected to be involved in the underlying biological mechanisms. Additionally, we investigated whether such features were present in the primary tumors. Preoperatively, 19 patients with recurrent DTC underwent PET. ¹⁸FDG uptake was compared with histological and immunohistochemical features in surgical specimens of recurrent and primary tumor. Thirteen of 19 recurrences were positive at PET, and ¹⁸FDG uptake was associated with the expression of hexokinase type I (HK I; P = 0.011). All lesions with HK I overexpression were positive on ¹⁸FDG PET. HK I expression in the original primary tumor and the metastases was similar in 82% ( = 0.648; P = 0.005). In suspected recurrent thyroid cancer, stratification for ¹⁸FDG PET may benefit from pretest immunohistochemical analysis of HK I of the primary tumor, as HK I negativity indicates a low likelihood of PET positivity.

This article has been cited by other articles:

				M. Gonzalez-Gronow, S. J. Kaczowka, S. Payne, F. Wang, G. Gawdi, and S. V. Pizzo Plasminogen Structural Domains Exhibit Different Functions When Associated with Cell Surface GRP78 or the Voltage-dependent Anion Channel J. Biol. Chem., November 9, 2007; 282(45): 32811 - 32820. [Abstract] [Full Text] [PDF]

				G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF]

				W. A. Weber Positron Emission Tomography As an Imaging Biomarker J. Clin. Oncol., July 10, 2006; 24(20): 3282 - 3292. [Abstract] [Full Text] [PDF]